Fertility

The convenience revolution in healthcare has arrived—and diagnostics are at the center of it. The Global Market for At-Home and Home Collection In Vitro Diagnostic (IVD) Testing, 2025–2030 provides a comprehensive analysis of one of the fastest-evolving sectors of the diagnostics industry. Covering both self-administered over-the-counter (OTC) tests and home collection kits analyzed in central…

The global in vitro diagnostics (IVD) market continues to expand in 2025, driven by powerful innovations in next-generation sequencing (NGS), microfluidics, and precision medicine that are transforming diagnostics into a more personalized, patient-centric field. IVD Test Procedure Volumes, 7th Edition (2025-2030) provides a comprehensive, data-driven analysis of global test volume trends, serving as a critical…

Kalorama Information’s Biomarkers in Diagnostics: Global Strategic Insights and Forecasts to 2031 provides a comprehensive analysis of the worldwide clinical diagnostic biomarker market, with forecasts from 2022 through 2031. The report examines diagnostic substances and tests used for disease detection, therapy selection, disease monitoring, and evaluation of treatment effectiveness across seven major product categories: infectious…

Kalorama Information’s Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women’s health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift—with women living longer than men—healthcare systems are under increasing pressure to recognize and address…

Now in its twelfth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast.

Worldwide Market for Point-of-Care…